Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Alpha- Antitrypsin Deficiency Treatment
1.2 Key Market Segments
1.2.1 Alpha- Antitrypsin Deficiency Treatment Segment by Type
1.2.2 Alpha- Antitrypsin Deficiency Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Alpha- Antitrypsin Deficiency Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Alpha- Antitrypsin Deficiency Treatment Market Competitive Landscape
3.1 Global Alpha- Antitrypsin Deficiency Treatment Sales by Manufacturers (2019-2024)
3.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Alpha- Antitrypsin Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alpha- Antitrypsin Deficiency Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alpha- Antitrypsin Deficiency Treatment Sales Sites, Area Served, Product Type
3.6 Alpha- Antitrypsin Deficiency Treatment Market Competitive Situation and Trends
3.6.1 Alpha- Antitrypsin Deficiency Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alpha- Antitrypsin Deficiency Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Alpha- Antitrypsin Deficiency Treatment Industry Chain Analysis
4.1 Alpha- Antitrypsin Deficiency Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Alpha- Antitrypsin Deficiency Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Alpha- Antitrypsin Deficiency Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Type (2019-2024)
6.3 Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Alpha- Antitrypsin Deficiency Treatment Price by Type (2019-2024)
7 Alpha- Antitrypsin Deficiency Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alpha- Antitrypsin Deficiency Treatment Market Sales by Application (2019-2024)
7.3 Global Alpha- Antitrypsin Deficiency Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Alpha- Antitrypsin Deficiency Treatment Sales Growth Rate by Application (2019-2024)
8 Alpha- Antitrypsin Deficiency Treatment Market Segmentation by Region
8.1 Global Alpha- Antitrypsin Deficiency Treatment Sales by Region
8.1.1 Global Alpha- Antitrypsin Deficiency Treatment Sales by Region
8.1.2 Global Alpha- Antitrypsin Deficiency Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Alpha- Antitrypsin Deficiency Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alpha- Antitrypsin Deficiency Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alpha- Antitrypsin Deficiency Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adverum Biotechnologies, Inc.
9.1.1 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.1.2 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.1.4 Adverum Biotechnologies, Inc. Business Overview
9.1.5 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment SWOT Analysis
9.1.6 Adverum Biotechnologies, Inc. Recent Developments
9.2 Alnylam Pharmaceuticals, Inc.
9.2.1 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.2.2 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.2.4 Alnylam Pharmaceuticals, Inc. Business Overview
9.2.5 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment SWOT Analysis
9.2.6 Alnylam Pharmaceuticals, Inc. Recent Developments
9.3 Applied Genetic Technologies Corporation
9.3.1 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Basic Information
9.3.2 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Overview
9.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.3.4 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment SWOT Analysis
9.3.5 Applied Genetic Technologies Corporation Business Overview
9.3.6 Applied Genetic Technologies Corporation Recent Developments
9.4 Arrowhead Pharmaceuticals, Inc.
9.4.1 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.4.2 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.4.4 Arrowhead Pharmaceuticals, Inc. Business Overview
9.4.5 Arrowhead Pharmaceuticals, Inc. Recent Developments
9.5 Carolus Therapeutics, Inc.
9.5.1 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.5.2 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.5.4 Carolus Therapeutics, Inc. Business Overview
9.5.5 Carolus Therapeutics, Inc. Recent Developments
9.6 Cevec Pharmaceuticals GmbH
9.6.1 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Basic Information
9.6.2 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Overview
9.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.6.4 Cevec Pharmaceuticals GmbH Business Overview
9.6.5 Cevec Pharmaceuticals GmbH Recent Developments
9.7 Dicerna Pharmaceuticals, Inc.
9.7.1 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.7.2 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.7.4 Dicerna Pharmaceuticals, Inc. Business Overview
9.7.5 Dicerna Pharmaceuticals, Inc. Recent Developments
9.8 Digna Biotech, S.L.
9.8.1 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.8.2 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.8.4 Digna Biotech, S.L. Business Overview
9.8.5 Digna Biotech, S.L. Recent Developments
9.9 Editas Medicine, Inc.
9.9.1 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.9.2 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.9.4 Editas Medicine, Inc. Business Overview
9.9.5 Editas Medicine, Inc. Recent Developments
9.10 Grifols, S.A.
9.10.1 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.10.2 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.10.4 Grifols, S.A. Business Overview
9.10.5 Grifols, S.A. Recent Developments
9.11 Inhibrx
9.11.1 Inhibrx Alpha- Antitrypsin Deficiency Treatment Basic Information
9.11.2 Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Overview
9.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.11.4 Inhibrx Business Overview
9.11.5 Inhibrx Recent Developments
9.12 Intellia Therapeutics, Inc.
9.12.1 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.12.2 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.12.4 Intellia Therapeutics, Inc. Business Overview
9.12.5 Intellia Therapeutics, Inc. Recent Developments
9.13 International Stem Cell Corporation
9.13.1 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Basic Information
9.13.2 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Overview
9.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.13.4 International Stem Cell Corporation Business Overview
9.13.5 International Stem Cell Corporation Recent Developments
9.14 Ionis Pharmaceuticals, Inc.
9.14.1 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.14.2 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.14.4 Ionis Pharmaceuticals, Inc. Business Overview
9.14.5 Ionis Pharmaceuticals, Inc. Recent Developments
9.15 Kamada Ltd.
9.15.1 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.15.2 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.15.4 Kamada Ltd. Business Overview
9.15.5 Kamada Ltd. Recent Developments
9.16 Polyphor Ltd.
9.16.1 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.16.2 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.16.4 Polyphor Ltd. Business Overview
9.16.5 Polyphor Ltd. Recent Developments
9.17 ProMetic Life Sciences Inc.
9.17.1 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.17.2 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.17.4 ProMetic Life Sciences Inc. Business Overview
9.17.5 ProMetic Life Sciences Inc. Recent Developments
9.18 rEVO Biologics, Inc.
9.18.1 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.18.2 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.18.4 rEVO Biologics, Inc. Business Overview
9.18.5 rEVO Biologics, Inc. Recent Developments
9.19 Sangamo BioSciences, Inc.
9.19.1 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Basic Information
9.19.2 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Overview
9.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Market Performance
9.19.4 Sangamo BioSciences, Inc. Business Overview
9.19.5 Sangamo BioSciences, Inc. Recent Developments
10 Alpha- Antitrypsin Deficiency Treatment Market Forecast by Region
10.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast
10.2 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Region
10.2.4 South America Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Alpha- Antitrypsin Deficiency Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Alpha- Antitrypsin Deficiency Treatment by Type (2025-2030)
11.1.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Alpha- Antitrypsin Deficiency Treatment by Type (2025-2030)
11.2 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Alpha- Antitrypsin Deficiency Treatment Sales (K Units) Forecast by Application
11.2.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings